Patents Assigned to ADAPT PHARMA LIMITED
  • Nasal drug products and methods of their use
    Patent number: 10085937
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: October 2, 2018
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 9775838
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: October 3, 2017
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 9707226
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: July 18, 2017
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss
  • Nasal drug products and methods of their use
    Patent number: 9561177
    Abstract: Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: February 7, 2017
    Assignees: ADAPT PHARMA LIMITED, OPIANT PHARMACEUTICALS
    Inventors: Fintan Keegan, Robert Gerard Bell, Roger Crystal, Michael Brenner Weiss